News

Dear COSTers

Dr. Thorat, MC Member from Ireland, will also be organizing a Young Investigator Session in European Materials Research...

Dear COSTers,

Dr. Thorat, MC member from Ireland, will edit a book entitled 'NANOMEDICINES FOR BREAST CANCER THERANOSTICS' which will be...

Picture of the CA17140 TS class

With the keynote lecture of Prof. Dganit Danino, from Haifa Technion (IL) on Cryo-TEM and other imaging techniques to characterize...

COST Action CA17140 is the first, pan-European interdisciplinary network of representatives from academic institutions and small and medium enterprises including clinical research organizations (CROs) devoted to the development of nanosystems carrying anticancer drugs from their initial design, pre-clinical testing of efficacy, pharmacokinetics and toxicity to the preparation of detailed protocols needed for the first phase of their clinical studies.

By promoting scientific exchanges, technological implementation and innovative solutions, the Action will provide a timely instrument to rationalize and focus research efforts at the EU level in dealing with the grand challenge of nanomedicine translation in cancer, one of the major and societal-burdening human pathologies.

Useful downloads
CA17140-e.pdf557.41 KB
European Cooperation in Science and Technology (COST) logo
EU flag logo

Funded by the Horizon 2020 Framework Programme
of the European Union